There will be three main topics: Treatment of Achilles Tendon Ruptures (ATR); where the Speakers will present their study data and new protocols; representing the state-of-the-art conservative treatment for ruptured achilles tendons as well as demonstrate cost analysis data from their clinics; Further there will be data presented about evidencebased treatment to offload diabetic foot ulcers to accelerate healing and prevent amputation. International Guidelines will be presented and how to transfer them into daily practice. The third topic is about oedema management and prevention of deep vein thrombosis in patients at high risk.
OPED develops, manufactures and sells innovative product concepts in the field of our core competence – modern Orthosis.
Replacing the uncomfortable plaster cast with a light, functional vacuum splint was the vision of the OPED founders. Their vision became reality in 1993, when the VACOped – still the most successful OPED product, even today – came onto the market. However, the OPED spirit of invention was in no way satisfied with just the VACOped, which is the state-of-the-art treatment nowadays. The product range has been expanded to encompass an entire family of vacuum orthoses. Whether it is torn ligaments, Achilles tendon rupture or a fractured wrist: OPED products offer optimum care with the highest degree of mobility and hygiene.
